Lots Of Promise In Tech And Biotech

Alberto Vilar, who heads Amerindo Investment Advisors, which manages some $7.5 billion, is convinced "religion will come back to investors" in the second half, as the market snaps smartly back on its way to much higher ground. Techs and biotechs will lead the next parade, says Vilar, whose flagship fund, Amerindo Technology Fund, has racked up 71% a year since its inception in 1996. Companies that enable enterprises to position themselves in the B2B market will be winners, says Vilar. He has launched two new funds, Amerindo Internet B2B Fund (up 68% since May 30), and Amerindo Health & Biotechnology Fund (up 39%), to bag such potential winners.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.